beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
about
L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunctionNa+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytesCaveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytesXenobiotic, bile acid, and cholesterol transporters: function and regulation.Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testingQuantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.Molecular mechanism of inhibition of the mitochondrial carnitine/acylcarnitine transporter by omeprazole revealed by proteoliposome assay, mutagenesis and bioinformaticsAssessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsMolecular and cellular physiology of renal organic cation and anion transport.Inhibition of gene expression of organic cation/carnitine transporter and antioxidant enzymes in oxazaphosphorines-induced acute cardiomyopathic rat models.Inhibition of OCTN2-mediated transport of carnitine by etoposide.Carnitine-related hypoglycemia caused by 3 days of pivalate antibiotic therapy in a patient with severe muscular dystrophy: a case report.Cisplatin-induced downregulation of OCTN2 affects carnitine wastingDrug-drug interactions involving membrane transporters in the human kidney.Identification of OCTN2 variants and their association with phenotypes of Crohn's disease in a Korean population.Excretion of biliary compounds during intrauterine life.Pharmaceutical and pharmacological importance of peptide transporters.Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).Arabidopsis thaliana mitochondrial glyoxalase 2-1 exhibits beta-lactamase activity.Timing and Duration of Drug Exposure Affects Outcomes of a Drug-Nutrient Interaction During Ontogeny.Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier.Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature.OCTN cation transporters in health and disease: role as drug targets and assay development.The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.Solute Carriers in the Blood-Brain Barier: Safety in Abundance.Xenobiotic transporters and kidney injury.Renal Drug Transporters and Drug Interactions.The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier.Chronopharmacological study of cephalexin in dogs.Independent organic cation transport activity of Na(+)-L-carnitine cotransport system in LLC-PK(1) cells.A Potential Biomarker for Acute Kidney Injury in Preterm Infants from Metabolic ProfilingInteraction of 2,4-Diaminopyrimidine-Containing Drugs Including Fedratinib and Trimethoprim with Thiamine Transporters.Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A.Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins.Protein phosphatase PP2A - a novel interacting partner of carnitine transporter OCTN2 (SLC22A5) in rat astrocytes.
P2860
Q24298663-19523C6B-7173-489E-804D-CC1504CADEB1Q28308215-249E314A-36B6-43F5-81A1-D06ED6236414Q28362820-3DDFFACD-2766-4416-9CB1-CC0F3C80BEDFQ28537671-4A31C3DB-4F88-4582-BA79-0B4547F20332Q33714593-29CECAB6-8B54-468D-8BF1-DE6D6D4BF311Q33939558-D93CC994-D9F9-4BAE-9D01-555F46E0B43AQ34384867-9752F32A-1283-4B18-A5AA-D9DC0168911BQ35070154-EBB004BE-131E-4A6A-ABCB-BEC573AB3460Q35155913-B9FFAC23-C3D9-4123-9D82-3455FDFDCBF7Q35795744-6B71C64E-72D3-41BE-85E6-83BF03062401Q35842999-70F0B270-12FB-46D2-8529-73D48F31D409Q36014607-BDBBEB4D-122C-48DC-8ECC-7620CD69C52FQ36302949-D4F9DE14-1EB8-423B-9B3E-C2140AD5AC31Q36307780-540E85F5-6A46-4FE7-96F3-4769EDDA02DDQ36491674-AD645615-D1D8-410E-BA16-E69B98875A14Q36543091-2E48C232-7EF0-460E-9BE4-57AC09B0BB55Q36674906-CED628CF-C641-4206-93DD-6F7CA19DFF32Q37122394-4369C63F-5539-4AF6-A8F4-82E42A1CE53EQ37139860-13B6FC8D-42FE-4436-9533-E142EBF74E81Q37162177-B55C4D23-1634-4F2F-AAE9-EFE478A7A2ECQ37353843-1DCFD911-C57B-4CB9-9C04-4E922F3742BCQ37666701-FAFFF02E-6C5A-49A2-B0C1-86297AA08D20Q37950461-65DC44E3-E80D-4CB9-9538-3F5941E6F2DCQ38105163-C99607BE-2DB9-4B6D-9068-C5034816F8ABQ38114865-DB59CC81-442C-4907-BB3E-9A18F050FEDDQ38888345-8BACFE7D-3027-4674-A03B-BAF2B497454DQ38922312-34B67915-003D-4D4B-BEB4-1284CFA744ECQ39098252-209F6DC2-8681-4D89-A83B-785D27AF39D5Q39140289-C12C4475-6A01-4B1F-ADB7-4480BED8F24CQ39391771-74EB9C57-5EBA-4F7A-957D-40726D00AA28Q40233336-2DFDAE20-1991-45EE-BEBA-9F3400DD661DQ40791979-8CECB456-9A2D-49A1-9A5C-4F1C1A5CDD0EQ42228034-FF21BA42-F1C1-45A6-B7E8-2C549D894892Q46032293-21610541-29AE-45C5-B962-75A89429F352Q46728936-CCC682BA-A52B-43E5-AFE5-B61BDBD453D5Q47895958-A2BE450D-EB90-4C05-81AE-1633631331C5Q48564025-32865D93-6F24-47F0-9BAB-1C1CAE330559
P2860
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
description
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2000
@ast
im Januar 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/01/21)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/01/21)
@nl
наукова стаття, опублікована в січні 2000
@uk
name
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@ast
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@en
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@nl
type
label
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@ast
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@en
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@nl
prefLabel
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@ast
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@en
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@nl
P2093
P2860
P356
P1476
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
@en
P2093
A. L. Carter
D. P. Rajan
F. H. Leibach
M. E. Ganapathy
V. Ganapathy
P2860
P304
P356
10.1074/JBC.275.3.1699
P407
P577
2000-01-21T00:00:00Z